Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: aTyr Pharma Inc., 3 years.
aTyr Pharma Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
aTyr Pharma Inc. May 1, 202599.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 27, 2026 | aTyr Pharma Inc. | Open-market purchase | +100,000 | $0.50 | $50,000 |
| Oct 9, 2025 | aTyr Pharma Inc. | Open-market purchase | +317,999 | $0.94 | $298,919 |
| Oct 8, 2025 | aTyr Pharma Inc. | Open-market purchase | +682,001 | $0.90 | $613,801 |
| Jul 24, 2024 | aTyr Pharma Inc. | Open-market purchase | +52,300 | $1.93 | $100,939 |
| Jul 23, 2024 | aTyr Pharma Inc. | Open-market purchase | +6,648 | $1.82 | $12,099 |
| Jul 22, 2024 | aTyr Pharma Inc. | Open-market purchase | +41,052 | $1.74 | $71,430 |
| May 10, 2023 | aTyr Pharma Inc. | Open-market purchase | +200,000 | $2.25 | $450,000 |
| Apr 26, 2023 | aTyr Pharma Inc. | Option exercise | +6,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.